First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions

EuroIntervention

Volumn 8, Issue 1, 2012, Pages 51-56

  Onsea, Kevin ^a   Agostoni, Pierfrancesco ^a   Samim, Mariam ^a   Voskuil, Michiel ^a   Kluin, Jolanda ^a   Budde, Ricardo ^a   Hendrikse, Jeroen ^a   Ramjankhan, Faiz ^a   Van Klarenbosch, Jan ^a   Doesburg, Pieter ^a   Sieswerda, Gertjan ^a   Stella, Pieter ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cerebral protection device; Stroke; TAVI

Indexed keywords

AGED; AORTA STENOSIS; ARTERY CATHETER; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION; CLINICAL ARTICLE; DEVICE SAFETY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; EMBOLIC PROTECTION DEVICE; FEMALE; FEMORAL ARTERY; HUMAN; INVASIVE PROCEDURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; PILOT STUDY; POSTOPERATIVE PERIOD; STROKE; SURGICAL APPROACH; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; DIFFUSION MAGNETIC RESONANCE IMAGING; EMBOLIC PROTECTION DEVICES; FEASIBILITY STUDIES; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTRACRANIAL EMBOLISM; MALE; NETHERLANDS; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84865452176     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8I1A9     Document Type: Article

References (17)

1. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Engl J Med. 2011;364:2187-98.
2. Aggarwal A, Dai D, Rumsfeld JS, Klein LW, Roe MT; American College of Cardiology National Cardiovascular Data Registry. Incidence and predictors of stroke associated with percutaneous coronary intervention. Am J Cardiol. 2009;104:349-53.
3. Keeley EC, Grines CL. Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol. 1998;32:1861-5.
4. Omran H, Schmidt H, Hackenbroch M, Illien S, Bernhardt P, von der Recke G, Fimmers R, Flacke S, Layer G, Pohl C, Lüderitz B, Schild H, Sommer T. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet. 2003;361:1241-6.
5. Kahlert P, Doettger P, Mori K, Al-Rashid F, Thielmann M, Wendt D, Jakob H, Erbel R, Eggebrecht H. TVT-95. Cerebral Embolization during Transcatheter Aortic Valve Implantation: A Transcranial Doppler Study. Paper presented at: Transcatheter Cardiovascular Therapeutics, 2010; Washington, DC.
6. Rodés-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bédard F, Doyle D, De Larochellière R, Jayasuria C, Villeneuve J, Marrero A, Côté M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18-28.
7. Astarci P, Glineur D, Kefer J, D'Hoore W, Renkin J, Vanoverschelde JL, El Khoury G, Grandin C. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and transapical approaches using Edwards Sapiens valve. Eur J Cardiothorac Surg. 2011;40:475-9.
8. Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, Johansson U, Wendt D, Jakob HG, Forsting M, Sack S, Erbel R, Eggebrecht H. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870-8.
9. Ghanem A, Muller A, Nahle CP, Kocurek J, Werner N, Hammerstingl C, Schild HH, Schwab JO, Mellert F, Fimmers R, Nickenig G, Thomas D. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55:1427-32.
10. Arnold M, Schulz-Heise S, Achenbach S, Ott S, Dörfler A, Ropers D, Feyrer R, Einhaus F, Loders S, Mahmoud F, Roerick O, Daniel WG, Weyand M, Ensminger SM, Ludwig J. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc Interv. 2010;3:1126-32.
11. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6:611-9.
12. Agostoni P, Voskuil M, Onsea K, Vermeersch P, Stella PR. Tools & Techniques: Percutaneous intervention of saphenous vein graft lesions. EuroIntervention. 2011;7:878-9.
13. Henry M, Polydorou A, Henry I, Polydorou AD, Hugel M. Carotid angioplasty and stenting under protection: advantages and drawbacks. Expert Rev Med Devices. 2008;5:591-603.
14. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842-50.
15. Walther T, Dewey T, Borger MA, Kempfert J, Linke A, Becht R, Falk V, Schuler G, Mohr FW, Mack M. Transapical aortic valve implantation: step by step. Ann Thorac Surg. 2009;87:276-83.
16. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69-76.
17. Nietlispach F, Wijesinghe N, Gurvitch R, Tay E, Carpenter JP, Burns C, Wood DA, Webb JG. An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv. 2010;3:1133-8.